| Literature DB >> 25066952 |
SeonJu Park1, Nguyen Xuan Nhiem2, Phan Van Kiem3, Chau Van Minh3, Bui Huu Tai3, Nanyoung Kim1, Hye Hyun Yoo4, Jae-Hyoung Song5, Hyun-Jeong Ko5, Seung Hyun Kim6.
Abstract
Eurycoma longifolia has been widely used for various traditional medicinal purposes in South-East Asia. In this study, five new quassinoids, eurylactone E (1), eurylactone F (2), eurylactone G (3), eurycomalide D (4), and eurycomalide E (5), along with ten known quassinoids (6-15) were isolated from the roots of E. longifolia. Their structures were determined by extensive spectroscopic methods, including 1D and 2D NMR, and MS spectra data. Among the isolated compounds, 13β-methyl,21-dihydroeurycomanone (6) has been reported as a synthetic derivative. However, it was isolated from the natural product for the first time in this study. The cytotoxic activities of fifteen compounds were evaluated against human lung cancer cell line, A549 and human cervical cancer cell line, HeLa.Entities:
Keywords: A549 (human lung cancer cell); Cytotoxicity; Eurycoma longifolia; HeLa (human cervical cancer cell); Quassinoid
Mesh:
Substances:
Year: 2014 PMID: 25066952 DOI: 10.1016/j.bmcl.2014.06.058
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.823